Skip to Content Skip navigation

CME: Advances in Immunotherapy Treatment for Non-Small Cell Lung Cancer

Contact: Tammi Ramsey
Contact phone: 270-706-1766
Contact email: tramsey@hmh.net

Registration
Registration Required: Yes

Available Dates

event banner. CME: Advances in Immunotherapy Treatment for Non-Small Cell Lung Cancer

Advanced Registration Required: Call (270) 706-1766

Time and Date: Tuesday, Sept. 12 from 5:30 p.m. – 7:00 p.m.

Location: Auditorium 5A, Hardin Memorial Hospital (Take Elevator A)

Presenter: Jill Kolesar, PharmD, MD, BCPS, FCCP

Details: This program will improve familiarity with new developments in immunotherapy needed to assist in the treatment of lung cancer and better recognize and manage immune-related side effects.

Objectives:
• Understand stage appropriate indications for NSCLC
• Describe the mechanism of action of recently approved immunotherapies.
• Assess and manage the unique adverse effect profile of immunotherapies.

Target Audience: All Physicians, Advance Practice Clinicians, Nurses, and Allied Health Professionals.

Disclosure Statement: Dr. Kloesar and the planning committee disclose that they have nothing to disclose.

Registration: Advanced Registration Required.

Additional Information:
Registration/Dinner – 5:30 p.m.
Program 6:00 p.m. – 7:00 p.m.

Please relate to us at registration if you have any special needs and we will try to accommodate you.

Hardin Memorial Hospital is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.

Hardin Memorial Hospital designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.